MGMT and ovarian carcinoma: MGMT is widely methylated in the promoter region in various carcinomas, including ovarian cancer (Chaudhry, Srinivasan, & Patel, 2009; Hochhauser et al., 2013; Pierini et al., 2014; Schiffgens et al., 2016).